Women's health imaging is one of the most commercially significant and technology-active segments in diagnostic imaging. Digital breast tomosynthesis — three-dimensional mammography — has become the standard of care in most developed markets, replacing conventional 2D mammography. AI-powered mammography reading assistance is reducing false positive rates and improving cancer detection. Hologic is the dominant company in mammography globally, with GE HealthCare, Siemens Healthineers, and Fujifilm as the primary competitors.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Digital Breast Tomosynthesis Market
• AI in Mammography
• Contrast-Enhanced Mammography
• Breast MRI
• Breast Ultrasound
• Hologic Competitive Leadership
• GE HealthCare, Siemens, Fujifilm Women's Health Strategy
• Screening Program Dynamics
Table of Contents
1. Executive Summary
2. Market Overview
3. Digital Breast Tomosynthesis Market
4. AI in Mammography
5. Contrast-Enhanced Mammography
6. Breast MRI
7. Breast Ultrasound
8. Hologic Competitive Leadership
9. GE HealthCare, Siemens, Fujifilm Women's Health Strategy
10. Screening Program Dynamics
11. Competitive Landscape
12. Regional Market Analysis
13. Strategic Conclusions and Recommendations
14. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Canon Medical
Fujifilm Healthcare
GE HealthCare
Hologic
iCAD
Philips
Siemens Healthineers
Volpara Health
